BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23989160)

  • 1. Fibronectin type III domains engineered to bind CD40L: cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of two complexes.
    Oganesyan V; Ferguson A; Grinberg L; Wang L; Phipps S; Chacko B; Drabic S; Thisted T; Baca M
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Sep; 69(Pt 9):1045-8. PubMed ID: 23989160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticalins Reveal High Plasticity in the Mode of Complex Formation with a Common Tumor Antigen.
    Schiefner A; Gebauer M; Richter A; Skerra A
    Structure; 2018 Apr; 26(4):649-656.e3. PubMed ID: 29526433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface-exposed loops and an acidic patch in the Scl1 protein of group A
    McNitt DH; Choi SJ; Keene DR; Van De Water L; Squeglia F; Berisio R; Lukomski S
    J Biol Chem; 2018 May; 293(20):7796-7810. PubMed ID: 29615492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein.
    Leahy DJ; Hendrickson WA; Aukhil I; Erickson HP
    Science; 1992 Nov; 258(5084):987-91. PubMed ID: 1279805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of tandem type III fibronectin domains from Drosophila neuroglian at 2.0 A.
    Huber AH; Wang YM; Bieber AJ; Bjorkman PJ
    Neuron; 1994 Apr; 12(4):717-31. PubMed ID: 7512815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification, crystallization and preliminary crystallographic studies of a two fibronectin type-III domain segment from chicken tenascin encompassing the heparin- and contactin-binding regions.
    Bisig D; Weber P; Vaughan L; Winterhalter KH; Piontek K
    Acta Crystallogr D Biol Crystallogr; 1999 May; 55(Pt 5):1069-73. PubMed ID: 10216309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of adnectin/protein complexes reveal an expanded binding footprint.
    Ramamurthy V; Krystek SR; Bush A; Wei A; Emanuel SL; Das Gupta R; Janjua A; Cheng L; Murdock M; Abramczyk B; Cohen D; Lin Z; Morin P; Davis JH; Dabritz M; McLaughlin DC; Russo KA; Chao G; Wright MC; Jenny VA; Engle LJ; Furfine E; Sheriff S
    Structure; 2012 Feb; 20(2):259-69. PubMed ID: 22325775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold.
    Koide A; Wojcik J; Gilbreth RN; Hoey RJ; Koide S
    J Mol Biol; 2012 Jan; 415(2):393-405. PubMed ID: 22198408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the tenth type III cell adhesion module of human fibronectin.
    Dickinson CD; Veerapandian B; Dai XP; Hamlin RC; Xuong NH; Ruoslahti E; Ely KR
    J Mol Biol; 1994 Mar; 236(4):1079-92. PubMed ID: 8120888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
    Rajan S; Choi M; Baek K; Yoon HS
    Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody.
    Karpusas M; Lucci J; Ferrant J; Benjamin C; Taylor FR; Strauch K; Garber E; Hsu YM
    Structure; 2001 Apr; 9(4):321-9. PubMed ID: 11525169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification, crystallization and preliminary X-ray diffraction analysis of recombinant human neutrophil-activating peptide 2 (rhNAP-2).
    Kungl AJ; Machius M; Huber R; Schwer C; Lam C; Aschauer H; Ehn G; Lindley IJ; Auer M
    FEBS Lett; 1994 Jun; 347(2-3):300-3. PubMed ID: 8034022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of short linear motif-mediated interactions through phage display of intrinsically disordered regions of the human proteome.
    Davey NE; Seo MH; Yadav VK; Jeon J; Nim S; Krystkowiak I; Blikstad C; Dong D; Markova N; Kim PM; Ivarsson Y
    FEBS J; 2017 Feb; 284(3):485-498. PubMed ID: 28002650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial design of an Anticalin directed against the extra-domain b for the specific targeting of oncofetal fibronectin.
    Gebauer M; Schiefner A; Matschiner G; Skerra A
    J Mol Biol; 2013 Feb; 425(4):780-802. PubMed ID: 23238252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural studies on MRG701 chromodomain reveal a novel dimerization interface of MRG proteins in green plants.
    Liu Y; Wu H; Yu Y; Huang Y
    Protein Cell; 2016 Nov; 7(11):792-803. PubMed ID: 27638467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fibronectin type III domain as a scaffold for novel binding proteins.
    Koide A; Bailey CW; Huang X; Koide S
    J Mol Biol; 1998 Dec; 284(4):1141-51. PubMed ID: 9837732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a heparin- and integrin-binding segment of human fibronectin.
    Sharma A; Askari JA; Humphries MJ; Jones EY; Stuart DI
    EMBO J; 1999 Mar; 18(6):1468-79. PubMed ID: 10075919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of novel FN3 domains with high stability by a consensus sequence approach.
    Jacobs SA; Diem MD; Luo J; Teplyakov A; Obmolova G; Malia T; Gilliland GL; O'Neil KT
    Protein Eng Des Sel; 2012 Mar; 25(3):107-17. PubMed ID: 22240293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Backbone dynamics of homologous fibronectin type III cell adhesion domains from fibronectin and tenascin.
    Carr PA; Erickson HP; Palmer AG
    Structure; 1997 Jul; 5(7):949-59. PubMed ID: 9261088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the interaction between transglutaminase 2 and fibronectin.
    Cardoso I; Østerlund EC; Stamnaes J; Iversen R; Andersen JT; Jørgensen TJ; Sollid LM
    Amino Acids; 2017 Mar; 49(3):489-500. PubMed ID: 27394141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.